XRTX
XORTX Therapeutics Inc
NASDAQ: XRTX · HEALTHCARE · BIOTECHNOLOGY
$2.86
+4.76% today
Updated 2026-04-30
Market cap
$4.22M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-2.80
Dividend yield
—
52W range
$2 – $7
Volume
1.5M
XORTX Therapeutics Inc (XRTX) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
4 of 8
Last 8 quarters
Avg EPS surprise
+64.6%
Last 4 quarters
Revenue YoY growth
—
Most recent quarter
EPS YoY growth
+44.4%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-3.1%
Last 2 reports
Positive reaction rate
0%
0 of 2 quarters
Largest single-day move
-3.2%
2025-11-13
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-03-02 | $-0.45 | +71.5% | $0.41 | $0.40 | -3.0% |
| 2025-11-13 | $-0.13 | +57.7% | $0.57 | $0.56 | -3.2% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-1.58 | $-0.45 | +71.5% | — | — |
| 2025-09-30 | $-0.32 | $-0.13 | +57.7% | — | — |
| 2025-06-30 | — | $-0.19 | — | — | — |
| 2025-03-31 | — | $0.04 | — | — | — |
| 2024-12-31 | $-0.41 | $-0.81 | -97.6% | — | — |
| 2024-09-30 | — | $-0.20 | — | — | — |
| 2024-06-30 | $-0.92 | $0.06 | +106.3% | — | — |
| 2024-03-31 | $-0.28 | $1.35 | +588.0% | — | — |
| 2023-12-31 | $-0.82 | $-0.64 | +22.0% | — | — |
| 2023-09-30 | $-0.19 | $-0.67 | -252.6% | — | — |
| 2023-06-30 | $-1.36 | $-0.80 | +41.2% | — | — |
| 2023-03-31 | $-0.15 | $-0.11 | +24.5% | — | — |
Frequently asked questions
Has XORTX Therapeutics Inc beaten earnings estimates?
XORTX Therapeutics Inc has beaten Wall Street EPS estimates in 4 of its last 8 quarterly reports, with an average EPS surprise of +64.6% over the last 2 quarters.
How does XRTX stock react to earnings?
XRTX stock has moved an average of -3.1% in the trading day following earnings over its last 2 reports, with positive reactions in 0% of those quarters.